ANISHA KOTHARI: Open Payments
NPI 1245827856 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,628 in 109 payments from 17 companies in 2025. Trend: 2023 $2,295 · 2024 $3,956 · 2025 $3,628
Food & beverage: $3,443Education: $185
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 18 | $658 |
| Janssen Biotech, Inc. | 14 | $515 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 18 | $343 |
| PFIZER INC. | 19 | $340 |
| Incyte Corporation | 9 | $315 |
| Regeneron Healthcare Solutions, Inc. | 6 | $243 |
| Amgen Inc. | 5 | $217 |
| E.R. Squibb & Sons, L.L.C. | 2 | $192 |
| Arcutis Biotherapeutics, Inc. | 1 | $166 |
| LEO Pharma Inc. | 3 | $155 |
Products named: NEMLUVIO, TREMFYA, OPZELURA, DUPIXENT, CIBINQO, OTEZLA, ILUMYA, Sotyktu.
Industry payments across IN — which companies pay providers there.
